{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:18:56Z","timestamp":1787750336632,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Survivors of the Fontan circulation increasingly develop late multisystem complications, including liver disease, cardiac dysfunction, and frailty, despite stable hemodynamics. Emerging metabolomic data demonstrate chronically elevated circulating bile acids in Fontan patients, implicating a previously underrecognized metabolic contributor to disease progression. Drawing parallels with diabetes mellitus, in which chronic hyperglycemia drives silent organ injury through metabolic memory, we propose that persistently elevated bile acids act as a similar pathogenic driver in the Fontan circulation. Bile acid\u2013mediated mitochondrial dysfunction, inflammation, and fibrosis may imprint early cellular injury that manifests clinically years later. This framework highlights the potential importance of early bile acid surveillance and timely metabolic intervention to prevent irreversible end-organ damage and improve long-term outcomes in Fontan patients.<\/jats:p>","DOI":"10.4103\/apc.apc_37_26","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:00:14Z","timestamp":1782133214000},"page":"307-311","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bile acid dysregulation in Fontan circulation: A Parallel to hyperglycemia in diabetes?"],"prefix":"10.4103","volume":"19","author":[{"given":"Ashish H.","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"R1-20260626","doi-asserted-by":"crossref","first-page":"101563","DOI":"10.1016\/j.jacadv.2024.101563","article-title":"Association of Fontan pathophysiology with plasma bile acids","volume":"4","author":"Shah","year":"2025","journal-title":"JACC Adv"},{"key":"R2-20260626","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"R3-20260626","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"R4-20260626","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.jacadv.2025.102203","article-title":"Fontan-associated diastolic dysfunction and bile acids: Mechanistic parallels with cirrhotic cardiomyopathy","volume":"4","author":"Shah","year":"2025","journal-title":"JACC Adv"},{"key":"R5-20260626","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","article-title":"An update on chronic complications of diabetes mellitus: From molecular mechanisms to therapeutic strategies with a focus on metabolic memory","volume":"30","author":"Yang","year":"2024","journal-title":"Mol Med"},{"key":"R6-20260626","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","article-title":"Metabolic memory: Mechanisms and diseases","volume":"9","author":"Dong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R7-20260626","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/metabo15090592","article-title":"Plasma lipidomic alterations in fontan circulation reflect cardiovascular functional reserve","volume":"15","author":"Surendran","year":"2025","journal-title":"Metabolites"},{"key":"R8-20260626","first-page":"01556","article-title":"Fontan circulation beyond preload: Metabolic pathways and mitochondrial stress","author":"Shah","year":"2025","journal-title":"Can J Cardiol"},{"key":"R9-20260626","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"key":"R10-20260626","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/liv.12438","article-title":"Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis","volume":"35","author":"Desai","year":"2015","journal-title":"Liver Int"},{"key":"R11-20260626","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.jhepr.2023.100911","article-title":"Cardiomyopathy in cirrhosis: From pathophysiology to clinical care","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep"},{"key":"R12-20260626","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00535-024-02168-x","article-title":"Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease","volume":"60","author":"Kogiso","year":"2025","journal-title":"J Gastroenterol"},{"key":"R13-20260626","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ahj.2025.08.011","article-title":"IMpact of therapY using coleSevelam treatment reducing bile acids in patients with fonTan cIrCulation (MYSTIC): Rationale and study design","volume":"291","author":"Shah","year":"2025","journal-title":"Am Heart J"},{"key":"R14-20260626","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cjcpc.2025.10.008","article-title":"Pan-Canadian registry, pan-system disease: Rethinking Fontan pathobiology","volume":"4","author":"Shah","year":"2025","journal-title":"CJC Pediatr Congenit Heart Dis"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_37_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:25:41Z","timestamp":1787747141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_37_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/apc.apc_37_26","relation":{},"ISSN":["0974-2069","0974-5149"],"issn-type":[{"value":"0974-2069","type":"print"},{"value":"0974-5149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}